![Goutham Narla](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Goutham Narla
Gründer bei Rappta Therapeutics Oy
Aktive Positionen von Goutham Narla
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Rappta Therapeutics Oy
![]() Rappta Therapeutics Oy BiotechnologyHealth Technology Rappta Therapeutics Oy operates as a biopharmaceutical company. It develops anti-cancer drugs activating protein phosphatase 2A. The company was founded by Goutham Narla and Mikko Lauri Sampsa Mannerkoski on March 20, 2019 and is headquartered in Helsinki, Finland. | Gründer | 20.03.2019 | - |
Technik-/Wissenschafts-/F&E-Leiter | 20.03.2019 | - | |
Direktor/Vorstandsmitglied | 20.03.2019 | - |
Karriereverlauf von Goutham Narla
Ehemalige bekannte Positionen von Goutham Narla
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Dual Therapeutics LLC
![]() Dual Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Dual Therapeutics LLC develops novel therapeutics for prostate cancer, lung cancer, and acute lymphoblastic leukemia. The company was founded in 2013 and is headquartered in Cleveland, OH. | Gründer | - | - |
Statistik
International
Finnland | 2 |
Vereinigte Staaten | 2 |
Operativ
Founder | 2 |
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Rappta Therapeutics Oy
![]() Rappta Therapeutics Oy BiotechnologyHealth Technology Rappta Therapeutics Oy operates as a biopharmaceutical company. It develops anti-cancer drugs activating protein phosphatase 2A. The company was founded by Goutham Narla and Mikko Lauri Sampsa Mannerkoski on March 20, 2019 and is headquartered in Helsinki, Finland. | Health Technology |
Dual Therapeutics LLC
![]() Dual Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Dual Therapeutics LLC develops novel therapeutics for prostate cancer, lung cancer, and acute lymphoblastic leukemia. The company was founded in 2013 and is headquartered in Cleveland, OH. | Commercial Services |
- Börse
- Insiders
- Goutham Narla
- Erfahrung